These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29514700)

  • 1. Impact of a genetic counseling requirement prior to genetic testing.
    Stenehjem DD; Au T; Sainski AM; Bauer H; Brown K; Lancaster J; Stevens V; Brixner DI
    BMC Health Serv Res; 2018 Mar; 18(1):165. PubMed ID: 29514700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
    Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
    Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
    J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in BRCA testing: when insurance coverage is not a barrier.
    Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
    Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.
    Hayden S; Mange S; Duquette D; Petrucelli N; Raymond VM;
    J Genet Couns; 2017 Aug; 26(4):859-865. PubMed ID: 28093663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.
    Chopra I; Kelly KM
    J Health Commun; 2017 Feb; 22(2):143-152. PubMed ID: 28112991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling.
    Godard B; Pratte A; Dumont M; Simard-Lebrun A; Simard J
    Genet Test; 2007; 11(1):45-54. PubMed ID: 17394392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Payer Constraints on Access to Genetic Testing.
    Whitworth P; Beitsch P; Arnell C; Cox HC; Brown K; Kidd J; Lancaster JM
    J Oncol Pract; 2017 Jan; 13(1):e47-e56. PubMed ID: 28084878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.
    Halbert CH; Wenzel L; Lerman C; Peshkin BN; Narod S; Marcus A; Corio C; Demarco T; Bellamy S
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):875-81. PubMed ID: 15159322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility intentions following testing for a BRCA1 gene mutation.
    Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1/2 genetic testing in the community setting.
    Chen WY; Garber JE; Higham S; Schneider KA; Davis KB; Deffenbaugh AM; Frank TS; Gelman RS; Li FP
    J Clin Oncol; 2002 Nov; 20(22):4485-92. PubMed ID: 12431973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-cultural validation of the Decisional Conflict Scale in a sample of French patients.
    Mancini J; Santin G; Chabal F; Julian-Reynier C
    Qual Life Res; 2006 Aug; 15(6):1063-8. PubMed ID: 16900286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.
    Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson M; Williams R; Tucker K;
    Psychooncology; 2008 Aug; 17(8):844-54. PubMed ID: 18613319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations.
    Kelly K; Leventhal H; Andrykowski M; Toppmeyer D; Much J; Dermody J; Marvin M; Baran J; Schwalb M
    J Genet Couns; 2004 Jun; 13(3):237-57. PubMed ID: 15604634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
    Nippert I; Schlegelberger B;
    Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.